These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 2124411)

  • 1. Clinical efficacy of current transdermal drug delivery systems: a retrospective evaluation.
    Berba J; Banakar U
    Am Pharm; 1990 Nov; NS30(11):33-7, 40-1. PubMed ID: 2124411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transdermal delivery of drugs.
    Brown L; Langer R
    Annu Rev Med; 1988; 39():221-9. PubMed ID: 3130771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse dermatologic reactions to transdermal drug delivery systems.
    Hogan DJ; Maibach HI
    J Am Acad Dermatol; 1990 May; 22(5 Pt 1):811-4. PubMed ID: 2112162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Your CE topic (No. 111). Clinical application of transdermal drug delivery systems (Part II).
    Lackner TE
    J Pract Nurs; 1990 Mar; 40(1):42-50. PubMed ID: 2109799
    [No Abstract]   [Full Text] [Related]  

  • 5. Transdermal drug delivery: a review of pharmaceutics, pharmacokinetics, and pharmacodynamics.
    Moore L; Chien YW
    Crit Rev Ther Drug Carrier Syst; 1988; 4(4):285-349. PubMed ID: 3133121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hercon technology for transdermal delivery of drugs.
    Shah KR; Ng S; Zeoli L; Haight V; Matz S; Kydonieus AF
    J Biomater Appl; 1986 Oct; 1(2):239-73. PubMed ID: 3146634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A review of contact dermatitis associated with transdermal therapeutic systems.
    Holdiness MR
    Contact Dermatitis; 1989 Jan; 20(1):3-9. PubMed ID: 2492460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The promise of transdermal drug delivery.
    Nimmo WS
    Br J Anaesth; 1990 Jan; 64(1):7-10. PubMed ID: 2105738
    [No Abstract]   [Full Text] [Related]  

  • 9. Structure-activity relationship of chemical penetration enhancers in transdermal drug delivery.
    Kanikkannan N; Kandimalla K; Lamba SS; Singh M
    Curr Med Chem; 2000 Jun; 7(6):593-608. PubMed ID: 10702628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Issues in contemporary drug delivery. Part VI: Advanced cardiac drug formulations.
    Hilleman DE; Banakar UV
    J Pharm Technol; 1992; 8(5):203-11. PubMed ID: 10121014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Skin hypersensitivity reactions to transdermal therapeutic systems--still an important clinical problem.
    Jenerowicz D; Polańska A; Olek-Hrab K; Silny W
    Ginekol Pol; 2012 Jan; 83(1):46-50. PubMed ID: 22384639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cutaneous reactions to transdermal therapeutic systems.
    Musel AL; Warshaw EM
    Dermatitis; 2006 Sep; 17(3):109-22. PubMed ID: 16956462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Testing of controlled-release transdermal dosage forms. Product development and clinical trials.
    Shaw JE; Prevo ME; Amkraut AA
    Arch Dermatol; 1987 Nov; 123(11):1548-56. PubMed ID: 2960274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Management of transdermal therapeutics in perioperative care].
    Gentile A; Tran-Van D; Dardare E; Fritsch N; Benois A; Fontaine B
    Ann Fr Anesth Reanim; 2009 Apr; 28(4):311-20. PubMed ID: 19304449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic characterisation of transdermal delivery systems.
    Berner B; John VA
    Clin Pharmacokinet; 1994 Feb; 26(2):121-34. PubMed ID: 8162656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapeutic systems and drug delivery. 3. Transdermal therapeutic systems].
    Davila D; Karleusa-Simanović A; Davila T
    Lijec Vjesn; 1990; 112(7-8):235-43. PubMed ID: 2292898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of nitroglycerin and clonidine delivered by the transdermal route.
    Shaw JE
    Am Heart J; 1984 Jul; 108(1):217-23. PubMed ID: 6428208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of substrates for 90 degrees peel adhesion--a collaborative study. II. Transdermal drug delivery systems.
    Wokovich AM; Brown SA; Shen M; Doub WH; Cai B; Sadrieh N; Chen ML; Machado S; Buhse LF
    J Biomed Mater Res B Appl Biomater; 2009 Jan; 88(1):61-5. PubMed ID: 18546200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of transdermal nitroglycerin in the treatment of coronary heart disease.
    Taylor SH
    Am Heart J; 1986 Jul; 112(1):197-207. PubMed ID: 3088957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanoparticle delivery for transdermal HRT.
    Valenzuela P; Simon JA
    Nanomedicine; 2012 Sep; 8 Suppl 1():S83-9. PubMed ID: 22640909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.